





19th CardioVascular Summit: TCTAP 2014when it involves the skin and other systems, most commonly the gastrointestinal tract
and the central nervous system. The malignant type is most common and is typically
fatal within two to three years from the time of onset of systemic involvement. The
most common complications and cause of death for subjects with Degos Disease are
gastrointestinal tract complications. The less common variant is the benign type with
only cutaneous involvement. In the skin, it manifests with erythematous, pink or red
papules. After healing, these papules leave scars with pathogonomic, central, porce-
lain white atrophic centers and a peripheral telangiectatic rim.
In a case by Pierce and Smith, they mention chronic pleuritis and pericarditis were
the major causes of morbidity. There are very few reported cases of pleuritis and
pericarditis, most diagnosed as incidental ﬁndings at autopsy. Another case by Notash
et al. mentioned that severe restrictive cardiopulmonary insufﬁciency led to death of a
patient with Degos disease. Another case with cardiopulmonary involvement was
reported in 1996. An infant case of Degos disease in which the patient died due to
disseminated myocardial infarct was presented by Cabre et al. Also, two cases of
constrictive pericarditis have been described. One of these cases underwent a peri-
cardiectomy but died four months later due to an intestinal hemorrhage. The other
case, described by Pierce and Smith, died due to heart failure and respiratory disorder
three months after a left lung decortication. Histology of the heart of both cases
indicated myocardial impairment. Pierce and Smith suggested that the myocardial
impairment was present with no evidence of associated lesions. Pleuritis and peri-
carditis were reported as symptoms of Degos Disease by Voigt et al. One case with
calciﬁc constrictive pericarditis and recurrent pleural effusions in a patient with long-
standing Degos Disease was also reported. Another case by Shahshahani et al pre-
sented a case in which the patient died due to severe cardiopulmonary failure and the
autopsy revealed severe diffuse ﬁbrotic thickening of the pericardium and pleura. One
case with endocardial involvement and positive anticardiolipin antibodies has been
reported. Malignant atrophic papulosis (Degos’ disease) was ﬁrst described by
Kohlmeier in 1941 and recognized as a speciﬁc entity by Degos in 1942.
Cardiopulmonary involvement is a rare but serious complication of DD. These
complications must be considered in the disease spectrum for this form of vasculopathy.
Our case is unique as it was diagnosed in a living patient currently being treated with
medications. The medications he was prescribed were cyclosporine, eculizumab, and
enoxaparin sodium. Had the illness not been diagnosed at an early stage, there is a
possibility the patient would not have survived. In this case, the pericarditis appeared to
be triggered by endothelial cell injury with resultant thrombosis and supervening





Cardiopulmonary involvement is a rare but serious complication of DD. These
complications must be considered in the disease spectrum for this form of vascul-
opathy. Our case is unique as it was diagnosed in a living patient currently being
treated with medications. The medications he was prescribed were cyclosporine,
eculizumab, and enoxaparin sodium. Had the illness not been diagnosed at an early
stage, there is a possibility the patient would not have survived. In this case, the
pericarditis appeared to be triggered by endothelial cell injury with resultant throm-
bosis and supervening ischemic complications. There is limited literature on this topic.
TCTAP C-173
Anchor-monorail Technique Using Goose-neck Snare for Challenging Case in
CRT Implantation
Tetsuya Ishiki, Masashi Iwabuchi
University of the Ryukyus Graduate, Japan
[Clinical Information]
Patient initials or identiﬁer number:
2822976
Relevant clinical history and physical exam:
A 56-year-old man without signiﬁcant previous cardiovascular history was ﬁrst
admitted to another hospital with decompensated congestive heart failure manifested
by signiﬁcant orthopnea and lower extremity edema. His symptom signiﬁcantly
improved with using diuretics, also Amiodarone and Pimobendan added against non-
sustained ventricular tachycardia and low output condition respectively. And then he
was referred to our hospital for advanced treatment for heart failure, right heart
catheterization and beta blocker titration. Patient had refused the CRT implantation
because of anxiety associated with operative treatment back then. After 1 year later he
was provoked syncope during walking, so re-admitted to our hospital for implantation
of CRT with implantable cardioverter deﬁbrillator (CRTD).
Relevant test results prior to catheterization:
Electrocardiography showed wide PR and QRS duration, 242ms and 186ms respec-
tively. Chest X ray shows marked cardiomegaly (CTR55%) and lung congestion.
Transthoracic echocardiography showed markedly dilated LV (76mm), reduced LV
ejection fraction (LVEF¼26%), and moderate to severe mitral regurgitation.
[Interventional Management]
Procedural step:
Blood access was gained via left subclavian vein using the Seldinger technique.
We tried to cannulate Guiding catheter (GC) into Coronary sinus (CS) with a usual
technique. But we could not get a CS ostium in spite of changing type of GC (CS-
H; model 7075, CS-A6; model 7078 (Amplatz), Boston Scientiﬁc Japan) and using
0.035’ guide wire (GW), inner catheter (CS-IC90) together with a ﬂuoroscopic
image. After right radial artery puncture was made and placed 4Fr Sheath, JL3.5JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/CAS(4Fr, model JL-35B-SH, TORAY MEDICAL, Japan) was advanced to left coro-
nary artery (LCA) ostium after injection of 2,000 u of Heparin. CS venography in
delayed phase of LCA angiogram delineated the courses and ostium of the CS. The
level of insertion of CS ostium located high above tricuspid annulus level. We
thought it seems to get CS using 0.035’ GW from femoral access because of
signiﬁcant disposition and tortuosity of proximal segment of CS ostium. If it was
feasible, we could apply “the Anchor-Monorail technique” using the Balloon
Angiographic with Endo Hole Catheter (BAC) as a rail after anchoring the BAC
into distal CS. More speciﬁcally, the Goose Neck Snares (GNS) was advanced into
RA through the GC via left subclavian access at ﬁrst. The BAC was advanced into
RA after placing 6Fr Sheath in right femoral vein on the next step. The BAC was
anchored into distal CS after putting the BAC through a loop of GNS in RA. We
tried to press the GC with GNS into CS with advancing GC with pulling back GNS
making the tip of the GC to slide on the shaft of anchored BAC. In spite of every
effort, we could not press the GNS into CS ostium. Eventually we could press the
GC with GNS into CS after advancing 0.035’ GW through GC into CS to make it
coaxial the axis of CS ostium and distal tip of the GC with giving traction for the
BAC anchored into CS simultaneously. A 0.014’ GW (WHISPERVIEWTM EDS
Guide Wire, model 4648, Boston Scientiﬁc Japan) was successfully advanced
through GC (CS-H, model 7075, Boston Scientiﬁc Japan) and placed into anterior-
lateral cardiac vein. The Unipolar IS-1 LV lead (ACUITYTM Spiral model 4592,
Boston Scientiﬁc Japan) was advanced over the wire without any difﬁculty.
Excellent pacing thresholds were obtained without any diaphragmatic stimuli. All
coronary sinus GC were split and withdrawn and GW were removed. CRTD
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Successful Treatment of a Pericardial Hemangioma with a Stent Graft
Chiate Liao, Jhih-Yen Shih, Jinn-Ming Chang, Wan-Ling Miriam Wu,
Wen-Shiann Wu, Zhih-Cheng Chen
Chimei Medical Center, Taiwan
[Clinical Information]
Patient initials or identiﬁer number:
A 53 years old woman without systemic disease presented to the emergency depart-
ment because of several episodes of atypical chest pain and palpitations.
Relevant clinical history and physical exam:
Her general physical examination showed decreased heart sounds.
Relevant test results prior to catheterization:
Her ECG, chest x-ray, and blood laboratory tests were unremarkable. Transthoracic
echocardiography revealed a moderate amount of pericardial effusion and a hyper-
echoic mass measuring 2.3 cm in length located to the left heart. Consequently, the
patient was admitted to the cardiology intensive care unit for further evaluation.
Advanced investigation of the mass was done using cardiac magnetic resonance im-
aging (MRI) and 256-slice computed tomography (CT). Cardiac MRI showed a
moving ovoid-shaped and well-deﬁned mass measuring 3.9  2.6 cm in the left
pericardial space which was favored to be a benign tumor. CT of the chest, with
intravenous contrast, disclosed a tumor with an ample blood supply along with a
hemopericardium. This tumor was heterogeneous on unenhanced phase, mildly
enhanced on arterial phase and intensely enhanced on venous phase after injection of
contrast medium. Besides, two liver hemangiomas were found incidentally.
Relevant catheterization ﬁndings:
Coronary angiography revealed a small tortuous feeding artery arising from left
circumﬂex artery and vascular lakes with “tumor blush” at the corresponding location.
[Interventional Management]
Procedural step:
Percutaneous coronary intervention was arranged. A 7-Fr JL4 guiding catheter was
inserted into the left coronary artery, and a 0.014-inch ﬂoppy guide wire was placed
into the distal left circumﬂex artery (LCX). The feeding artery of the cardiac hem-
angioma was too small to perform coil embolization. Therefore, a 3.5  19-mm
Jostent GraftMaster (coronary graft stent, Jomed, Helsingborg, Sweden) was advanced
into the LCX without predilatation to close the oriﬁce of the feeding artery. The stent
graft was deployed at 14 atmospheres and was dilated using a 4.0  12-mm balloon at
14 atmospheres to obliterate the coronary blood ﬂow into the feeding artery of the
cardiac hemangioma. After deployment of the stent graft, the patient received dual
antiplatelet therapy with aspirin 100 mg and clopidogrel 75 mg per day for three
months, after which the patient was maintained on clopidogrel 75mg per day.S174 JACC Vol 63/12/Suppl SCase Summary:
Cardiac hemangiomas are rare, non-malignant vascular tumors with diverse clincial
presentations. The current treatment of cardiac hemangiomas depends on the clinical
symptoms, and the primary treatment option is surgical resection. Coronary stent
grafts have been used for treatment of coronary artery perforation, coronary pseu-
doaneurysm, and coronary artery ﬁstula. In this article, we presented a 53 years old
female patient with cardiac hemangioma complicated by pericardial effusion was
treated with a stent graft. While surgical resection is the mainstay of treatment, cor-
onary stent graft implantation may be an effective option for patients that need less
invasive treatment for cardiac hemangiomas.j April 22–25, 2014 j TCTAP Abstracts/CASE/Other (Unclassiﬁed)
